statistiche ricercatore

Continente	#
NA - Nord America	1.017
EU - Europa	681
AS - Asia	494
SA - Sud America	124
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.335

Nazione	#
US - Stati Uniti d'America	1.004
RU - Federazione Russa	183
CN - Cina	135
SG - Singapore	132
IE - Irlanda	114
GB - Regno Unito	99
BR - Brasile	97
VN - Vietnam	90
IT - Italia	78
SE - Svezia	53
HK - Hong Kong	40
FR - Francia	30
UA - Ucraina	30
DE - Germania	29
IN - India	22
FI - Finlandia	19
KR - Corea	14
ZA - Sudafrica	13
BD - Bangladesh	12
AR - Argentina	10
TR - Turchia	10
CA - Canada	9
NL - Olanda	9
AT - Austria	7
BE - Belgio	6
CZ - Repubblica Ceca	5
ID - Indonesia	5
AZ - Azerbaigian	4
CH - Svizzera	4
ES - Italia	4
JP - Giappone	4
KZ - Kazakistan	4
UZ - Uzbekistan	4
EC - Ecuador	3
EG - Egitto	3
IQ - Iraq	3
MX - Messico	3
PK - Pakistan	3
PL - Polonia	3
PY - Paraguay	3
UY - Uruguay	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
CO - Colombia	2
LT - Lituania	2
PT - Portogallo	2
SA - Arabia Saudita	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
BO - Bolivia	1
CL - Cile	1
CR - Costa Rica	1
GR - Grecia	1
IL - Israele	1
IR - Iran	1
MA - Marocco	1
NG - Nigeria	1
NO - Norvegia	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
TH - Thailandia	1
TL - Timor Orientale	1
TM - Turkmenistan	1
TW - Taiwan	1
Totale	2.335

Nome	#
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform	279
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections	274
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity	266
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs	264
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery	250
Development of flavonol and flavanone derivatives as anti-trypanosomatidic drugs	218
High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor	199
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors	186
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases	167
Multitarget, selective compound design yields potent inhibitors of a Kinetoplastid Pteridine Reductase 1	160
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents	130
Totale	2.393

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	39	0	0	0	0	0	0	0	0	0	0	0	39
2021/2022	150	3	22	17	19	9	4	6	10	7	9	15	29
2022/2023	152	8	9	26	11	16	38	3	14	18	2	5	2
2023/2024	189	9	3	17	14	4	50	61	3	2	6	0	20
2024/2025	324	12	15	30	11	40	28	8	16	35	11	38	80
2025/2026	966	55	130	129	169	187	28	81	23	59	54	45	6
Totale													2.393